Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Genomic technology could accelerate patient trials of new cancer drugs that are targeted to a tumor’s individual molecular profile.
Several gene therapies are or will soon be in late-stage human trials. One of them could be the first to get FDA approval for sale in the U.S.
A unique class of RNA drugs could bring new treatments to cancer and other diseases.
Technologies that can pull tumor cells from patients’ blood are giving researchers an unprecedented look at cancer.
Advanced genetic engineering is already changing vaccine development and could make inroads into other branches of medicine.
Genomics signatures in uterine cancers could offer clues to prognosis.
Genetic logic gates will enable biologists to program cells for chemical production and disease detection.
Patients can turn off an experimental treatment if side effects get too bad.